Literature DB >> 20540933

Hispolon promotes MDM2 downregulation through chaperone-mediated autophagy.

Te-Ling Lu1, Guan-Jhong Huang, Huang-Joe Wang, Jian-Lian Chen, Hui-Ping Hsu, Te-Jung Lu.   

Abstract

Amplification and overexpression of murine double minute (MDM2) has been observed in several human cancers. Some chemotherapeutic agents cause MDM2 ubiquitination and degradation in a proteasome-dependent system. In addition to the proteasome system, chaperone-mediated autophagy (CMA) is a lysosomal pathway for selective misfolded protein degradation. Molecular chaperone heat shock cognate 70 protein (Hsc70) recognizes the misfolded proteins, which are then delivered to lysosome-associated membrane protein type 2A (LAMP2A) for lysosomal degradation. Our previous study reported that hispolon was able to induce cell apoptosis and downregulate MDM2 expression. In this study, our results showed that the proteasome inhibitor, MG132, could not inhibit hispolon-induced MDM2 downregulation. In contrast, both inhibition of lysosomes with NH(4)Cl and inhibition of LAMP2A using siRNA partially attenuated hispolon-induced MDM2 downregulation. To determine whether Hsc70 recognizes MDM2 on amino acids 135-141, SMP14 antibody was used to compete with Hsc70 for interaction with MDM2. After Hsc70 knockdown, SMP14 antibody immunoprecipitated increased MDM2. We also found that hispolon induced increased association of Hsp70, Hsc70, Hsp90 and LAMP2A with MDM2. This association was inhibited in cells pretreated with geldanamycin (GA), an Hsp90 inhibitor. GA also attenuated hispolon-induced MDM2 downregulation. Meanwhile, inhibition of Hsc70 using siRNA attenuated hispolon-induced MDM2 downregulation. Our study provides the first example of the ability of hispolon to mediate MDM2 downregulation in lysosomes through the CMA pathway. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20540933     DOI: 10.1016/j.bbrc.2010.06.004

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  18 in total

Review 1.  The coming of age of chaperone-mediated autophagy.

Authors:  Susmita Kaushik; Ana Maria Cuervo
Journal:  Nat Rev Mol Cell Biol       Date:  2018-06       Impact factor: 94.444

2.  Hispolon inhibits TPA-induced invasion by reducing MMP-9 expression through the NF-κB signaling pathway in MDA-MB-231 human breast cancer cells.

Authors:  Yi-Sheng Sun; Zhao Zhao; Han-Ping Zhu
Journal:  Oncol Lett       Date:  2015-05-18       Impact factor: 2.967

Review 3.  Pros and Cons of Chaperone-Mediated Autophagy in Cancer Biology.

Authors:  Esperanza Arias; Ana Maria Cuervo
Journal:  Trends Endocrinol Metab       Date:  2019-11-04       Impact factor: 12.015

Review 4.  Dysfunction of chaperone-mediated autophagy in human diseases.

Authors:  Zhaozhong Liao; Bin Wang; Wenjing Liu; Qian Xu; Lin Hou; Jinlian Song; Qingming Guo; Ning Li
Journal:  Mol Cell Biochem       Date:  2021-01-03       Impact factor: 3.396

5.  Chaperone-mediated autophagy and disease: Implications for cancer and neurodegeneration.

Authors:  Raquel Gómez-Sintes; Esperanza Arias
Journal:  Mol Aspects Med       Date:  2021-10-07

6.  Targeting Chaperone-Mediated Autophagy for Disease Therapy.

Authors:  Wenming Li; Juan Dou; Jing Yang; Haidong Xu; Hua She
Journal:  Curr Pharmacol Rep       Date:  2018-05-02

Review 7.  Autophagy in major human diseases.

Authors:  Daniel J Klionsky; Giulia Petroni; Ravi K Amaravadi; Eric H Baehrecke; Andrea Ballabio; Patricia Boya; José Manuel Bravo-San Pedro; Ken Cadwell; Francesco Cecconi; Augustine M K Choi; Mary E Choi; Charleen T Chu; Patrice Codogno; Maria Isabel Colombo; Ana Maria Cuervo; Vojo Deretic; Ivan Dikic; Zvulun Elazar; Eeva-Liisa Eskelinen; Gian Maria Fimia; David A Gewirtz; Douglas R Green; Malene Hansen; Marja Jäättelä; Terje Johansen; Gábor Juhász; Vassiliki Karantza; Claudine Kraft; Guido Kroemer; Nicholas T Ktistakis; Sharad Kumar; Carlos Lopez-Otin; Kay F Macleod; Frank Madeo; Jennifer Martinez; Alicia Meléndez; Noboru Mizushima; Christian Münz; Josef M Penninger; Rushika M Perera; Mauro Piacentini; Fulvio Reggiori; David C Rubinsztein; Kevin M Ryan; Junichi Sadoshima; Laura Santambrogio; Luca Scorrano; Hans-Uwe Simon; Anna Katharina Simon; Anne Simonsen; Alexandra Stolz; Nektarios Tavernarakis; Sharon A Tooze; Tamotsu Yoshimori; Junying Yuan; Zhenyu Yue; Qing Zhong; Lorenzo Galluzzi; Federico Pietrocola
Journal:  EMBO J       Date:  2021-08-30       Impact factor: 14.012

Review 8.  Chaperone-mediated autophagy in cancer: Advances from bench to bedside.

Authors:  Tao Hou; Yizeng Fan; Weichao Dan; Bo Liu; Zixi Wang; Jin Zeng; Lei Li
Journal:  Histol Histopathol       Date:  2020-01-22       Impact factor: 2.303

9.  p53 causes butein‑mediated apoptosis of chronic myeloid leukemia cells.

Authors:  Sang-Mi Woo; Youn Kynug Choi; Ah Jeong Kim; Sung-Gook Cho; Seong-Gyu Ko
Journal:  Mol Med Rep       Date:  2015-12-10       Impact factor: 2.952

Review 10.  The different roles of selective autophagic protein degradation in mammalian cells.

Authors:  Da-wei Wang; Zhen-ju Peng; Guang-fang Ren; Guang-xin Wang
Journal:  Oncotarget       Date:  2015-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.